People: NIH Neurobiologist Is Named As First Craigie Scholar by University Of Toronto

Milton W. Brightman, section chief on brain structural plasticity in the Laboratory of Neurobiology at the National Institutes of Health, has been appointed the first Edward Horne Craigie Scholar. The honor is named for the noted biomedical scientist who conducted pioneering research on brain capillaries. Craigie, who died last year at the age of 94, was associated with the University of Toronto's departments of biology and zoology for more than 70 years. To honor Craigie, present and former f

Written byColby Stong
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Milton W. Brightman, section chief on brain structural plasticity in the Laboratory of Neurobiology at the National Institutes of Health, has been appointed the first Edward Horne Craigie Scholar. The honor is named for the noted biomedical scientist who conducted pioneering research on brain capillaries. Craigie, who died last year at the age of 94, was associated with the University of Toronto's departments of biology and zoology for more than 70 years.

To honor Craigie, present and former faculty members of the University of Toronto have established the Craigie Conference on Brain Capillaries. The conference, expected to become a biannual event, is devoted to international research focusing on brain capillaries' structure and function. The first Craigie Conference was held at the university on Craigie's birthday, June 24. At this meeting, Brightman presented the opening lecture, "Circumventing the Blood-Brain Barrier."

Brightman, 67, is a former student of Craigie's. His mentor "was, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies